Specialty Enzymes Market

Global Specialty Enzymes Market Size (2024 to 2029)

As per our report, the global specialty enzymes market is estimated to grow at a CAGR of 9.1% from 2024 to 2029, and the market size is expected to grow from USD 5103 million in 2024 to USD 7888 million by 2029. 

MARKET DRIVERS

The growing usage of specialty enzymes for diagnosing various diseases is propelling the global specialty enzymes market growth.

The rising prevalence of metabolic disorders further drives the global specialty enzymes market. The growing prevalence of diseases linked to metabolism is fuelling the market for specialty enzymes. The increased understanding of enzymes in recent years has increased the need for enzymes to treat various illnesses. Familial hypercholesterolemia, Gaucher disease, liver cirrhosis, Krabbe disease, Metachromatic leukodystrophy, Mitochondrial encephalopathy, diabetes, stroke-like episodes (MELAS), Niemann-Pick disease, Phenylketonuria (PKU), heart disease, Tay-Sachs disease, and Wilson's disease are some of the conditions that can be treated with it. In addition, a metabolic syndrome is a group of diseases that develop in tandem and raise your risk of heart disease, stroke, and type 2 diabetes. These diseases include increased blood pressure, excessive blood sugar, extra body fat around the waist, and abnormal cholesterol or triglyceride levels. Metabolic syndrome presently affects over a billion individuals throughout the world. The need for enzymatic treatments is growing due to this growing incidence.

The market for specialty enzymes is expected to benefit from advancements in enzyme engineering.

Nonetheless, advances in enzyme engineering will create lucrative possibilities for expanding the healthcare specialty enzymes market. For example, enzyme engineering is increasingly being used to improve the stability of enzymes. Furthermore, recent advances in protein engineering have opened new scope for more efficient biocatalyst production, particularly the combination of multidisciplinary techniques such as post-translational enzyme modification, structured assisted protein tailoring, and computational modeling approaches. These advancements will ensure that healthcare specialty enzymes have a bright future.

Impact of COVID-19 on the Global Specialty Enzymes Market

COVID-19 has accelerated the demand for specialty enzymes. The current COVID-19 epidemic is driving up demand for healthcare specialty enzymes worldwide. These enzymes are crucial for diagnosing covid – 19. For example, to diagnose clinical samples of SARS-CoV-2, the RT-qPCR was developed using RNA extraction and novel methods. In addition, many industrial companies are working on it to develop a cure for coronavirus infections. For example, Richcore Lifesciences, an Indian biotechnology firm, plans to develop two pivotal enzyme components, which will be used primarily in the COVID-19 diagnostic kits based on Reverse Transcription Polymerase Chain Reaction (RT-PCR). A nucleic acid amplification test (NAAT) that identifies one or more RNA gene targets unique to the virus is suggested to diagnose acute or current SARS-CoV-2 infection. In addition, this technique may be used to screen symptomatic patients, those exposed to COVID-19, and those living in a high-prevalence region. As a result, Creative Enzymes, a U.S.-based producer, has expanded its line of healthcare specialty enzymes, recognizing the current usage of NAT and serological testing for COVID-19 diagnosis. In addition, there has been an increase in research and development activities for healthcare specialty enzymes to address these COVID-19 issues. For example, specialty Enzymes & Probiotics evaluates the safety and efficacy of the health supplements ImmunoSEB^TM (systemic enzyme complex) and ProbioSEB CSC3TM (Bacillus probiotics complex) as supplemental therapy in COVID-19 patients with verified mild to moderate disease.

REPORT COVERAGE

SEGMENTAL ANALYSIS

Global Specialty Enzymes Market Analysis By Source

Based on the source, owing to the unique features produced in enzymes originating from microbes, the microorganisms segment accounted for a significant share of the specialty enzymes market in 2023. Fermented microbial enzyme products provide several benefits, including a wide range of pH, temperature, and substrate specificities.

Global Specialty Enzymes Market Analysis By Type

Based on the type, the polymerases and nucleases segment is expected to dominate the market during the forecast period. The rising usage of the segment in specialist applications such as medicines, research & biotechnology, diagnostics, and biocatalysts is attributable to its rise. In addition, these enzymes catalyze the production of deoxyribonucleic acid (DNA) and ribonucleic acid (RNA) polymers.

Specialty Enzymes Market Analysis By Application

The pharmaceutical segment is expected to have the greatest CAGR based on the application. In the pharmaceutical business, specialty enzymes are mainly used for medication manufacturing, illness diagnosis, or therapy. In addition, the increased use of enzymes in treatments for cancer, cardiovascular disease, lysosomal storage disorders, and pain and inflammation control, among other diseases, is fuelling the segment's growth.

REGIONAL ANALYSIS

Geographically, the North American specialty enzymes market held the highest share in the global market in 2023. Enzymes are now accessible for a wide range of applications due to rapid developments in this area, and this sector is expected to drive market expansion in the region. Furthermore, due to the development of innovative and better-performing goods worldwide, this area is expected to be the largest market. As a result, the United States controls a large portion of the North American specialized enzyme market.

In the global market, the specialty enzymes market in Europe held the second-largest share of the worldwide market in 2023. Medicinal enzymes are in more demand as Europe's population ages. Furthermore, as healthcare expenses grow, advanced enzymes such as immobilized enzymes are becoming increasingly popular.

The Asia Pacific specialty enzymes market is projected to be driven by a rise in population and disposable income among consumers in emerging economies such as China and India. However, the Asia-Pacific region has the largest future development potential because of rising per capita healthcare expenditures, increased awareness of enzyme treatment, and a fast-expanding pharmaceutical manufacturing base.

The Latin America specialty enzymes market is expected to witness a healthy CAGR during the forecast period and is predicted to hold considerable occupancy worldwide.

The specialty enzymes market in MEA is expected to capture a moderate share of the global market in the coming years.

KEY MARKET PLAYERS

Companies such as Bbi Enzymes Ltd., Basf, Codexis Inc., Nagase & Co. Ltd., Life Technologies, Advanced Enzyme Technology Ltd. Affymetrix Inc., Advanced Enzyme Technology Ltd., Amano Enzyme Inc., Roche Holding Ag., and Sanofi S.A. are playing a leading role in the global specialty enzymes market. These players focus on launches, joint ventures and consolidations, and acquisitions to expand their global reach while improving their product portfolio.

RECENT MARKET HAPPENINGS

• In April 2019, DuPont Nutrition & Biosciences announced its industry-leading OPTIMASE range. Bio-based enzymes are included in this portfolio and will be utilized to clean medical devices.
• In December 2019, Roche Holding (Switzerland) and Codexis (US) signed an agreement to supply enzymes. Roche will get EvoT4 DNA ligase from Codexis. EvoT4 DNA ligase is a molecular diagnostic enzyme with good performance.
• In June 2019, Novozymes (Denmark) extended its foothold in East Africa. As a result, the firm was able to fulfill the region's need for enzyme goods. Novozymes is a global leader in biological solutions, manufacturing industrial enzymes and microorganisms for various industries, including the food industry.

This research report on the global specialty enzymes market has been segmented and sub-segmented into the following categories.

By Type

• Protease
• Lipase
• Carbohydrase
• Polymerases & Nucleases

By Type

• Protease
• Lipase
• Carbohydrase
• Polymerases & Nucleases

By Application:

• Research & Biotechnology
• Diagnostics
• Pharmaceutical
• Biocatalyst

By Region

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East and Africa